Thomas Foo, | |
900 Kiely Blvd, Santa Clara, CA 95051-5329 | |
(408) 236-6122 | |
(408) 236-4234 |
Full Name | Thomas Foo |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 900 Kiely Blvd, Santa Clara, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275621088 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | RPH35408 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Thomas Foo, 4724 Cielo Vista Way, San Jose, CA 95129-1446 Ph: () - | Thomas Foo, 900 Kiely Blvd, Santa Clara, CA 95051-5329 Ph: (408) 236-6122 |
News Archive
A world-first University of Sydney randomised controlled trial comparing continuity of midwifery care throughout pregnancy with standard public hospital care found that caseload midwifery reduced interventions in birth and reduced costs.
WuXi PharmaTech, a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, with operations in China and the United States, announced that it had been selected for the Deloitte Technology Fast 500 Asia Pacific 2009 List, the only company in China to receive this award for the past six years. The Deloitte program recognizes technology companies in the Asia Pacific region that have achieved the highest rates of revenue growth during the preceding three years.
Diagnoplex SA, a developer of molecular diagnostics for colorectal cancer and Unilabs, a leading supplier of clinical laboratory and medical diagnostic imaging services in Europe, signed a collaboration agreement to commercialize Colox, a minimally invasive colorectal cancer assay within the Unilabs network. The test will be available initially in the Swiss and Swedish markets.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that its selective histone deacetylase (HDAC) inhibitors will be featured in five posters and one oral presentation at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place December 8-11, 2012, in Atlanta, Georgia.
› Verified 3 days ago
Simo Yao, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 710 Lawrence Expy Dept 362, Santa Clara, CA 95051 Phone: 408-530-2809 | |
Mr. Clement Taiyin Wong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 N Winchester Blvd, Santa Clara, CA 95050 Phone: 408-247-1894 | |
Szu-wen Kung, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3118 Via Siena Pl, Santa Clara, CA 95051 Phone: 415-728-4881 | |
Dr. Khanh-linh Guerrero, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 Lawrence Expy, Santa Clara, CA 95051 Phone: 408-851-7500 | |
Patrick Nguyen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 Lawrence Expy, Dept 301, Santa Clara, CA 95051 Phone: 408-851-7492 | |
Dr. Jeannette Sagun Sanchez, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 710 Lawrence Expy, Department Of Clinical Pharmacy, Santa Clara, CA 95051 Phone: 408-851-3972 Fax: 408-851-3094 | |
Carrie Hazelton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 Kiely Blvd, Santa Clara, CA 95051 Phone: 408-236-5225 |